2023
DOI: 10.1136/ejhpharm-2022-003632
|View full text |Cite
|
Sign up to set email alerts
|

Risk of exposure of patients’ family members to lenalidomide at home

Abstract: ObjectivesLenalidomide, a hazardous drug, has strict distribution controls. However, the risk of contamination with lenalidomide when patients take the drug has not been studied and the risk of drug exposure to people in the patient’s living environment is unknown. Thus, we investigated the amount of lenalidomide that could be dispersed during the period between removal of the capsule and returning the used blister packages, and we considered the conditions under which lenalidomide could be dispersed and count… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 17 publications
(22 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?